Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003556266 | SCV004300053 | pathogenic | not provided | 2024-01-06 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the TYMP gene (p.Gly363Glufs*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 120 amino acid(s) of the TYMP protein and extend the protein by an uncertain number of additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TYMP-related conditions. ClinVar contains an entry for this variant (Variation ID: 223083). This variant results in an extension of the TYMP protein. Other variant(s) that result in a similarly extended protein product (p.Phe473Serfs*?) have been determined to be pathogenic (PMID: 21412940). This suggests that these extensions are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000208695 | SCV000264565 | pathogenic | Mitochondrial DNA depletion syndrome 1 | 2016-01-14 | no assertion criteria provided | literature only | |
Genomics England Pilot Project, |
RCV000208695 | SCV001760495 | pathogenic | Mitochondrial DNA depletion syndrome 1 | no assertion criteria provided | clinical testing |